1. Home
  2. EDAP vs PPCB Comparison

EDAP vs PPCB Comparison

Compare EDAP & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • PPCB
  • Stock Information
  • Founded
  • EDAP 1979
  • PPCB 2007
  • Country
  • EDAP France
  • PPCB Australia
  • Employees
  • EDAP N/A
  • PPCB N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PPCB
  • Sector
  • EDAP Health Care
  • PPCB
  • Exchange
  • EDAP Nasdaq
  • PPCB Nasdaq
  • Market Cap
  • EDAP 46.7M
  • PPCB 39.1M
  • IPO Year
  • EDAP 1997
  • PPCB N/A
  • Fundamental
  • Price
  • EDAP $2.15
  • PPCB $1.91
  • Analyst Decision
  • EDAP Buy
  • PPCB
  • Analyst Count
  • EDAP 3
  • PPCB 0
  • Target Price
  • EDAP $8.50
  • PPCB N/A
  • AVG Volume (30 Days)
  • EDAP 45.6K
  • PPCB 316.9K
  • Earning Date
  • EDAP 11-06-2025
  • PPCB 09-30-2025
  • Dividend Yield
  • EDAP N/A
  • PPCB N/A
  • EPS Growth
  • EDAP N/A
  • PPCB N/A
  • EPS
  • EDAP N/A
  • PPCB N/A
  • Revenue
  • EDAP $74,008,221.00
  • PPCB N/A
  • Revenue This Year
  • EDAP N/A
  • PPCB N/A
  • Revenue Next Year
  • EDAP N/A
  • PPCB N/A
  • P/E Ratio
  • EDAP N/A
  • PPCB N/A
  • Revenue Growth
  • EDAP 1.56
  • PPCB N/A
  • 52 Week Low
  • EDAP $1.21
  • PPCB $1.25
  • 52 Week High
  • EDAP $3.08
  • PPCB $145.46
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 48.68
  • PPCB N/A
  • Support Level
  • EDAP $2.25
  • PPCB N/A
  • Resistance Level
  • EDAP $2.79
  • PPCB N/A
  • Average True Range (ATR)
  • EDAP 0.21
  • PPCB 0.00
  • MACD
  • EDAP -0.06
  • PPCB 0.00
  • Stochastic Oscillator
  • EDAP 27.38
  • PPCB 0.00

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: